Patient characteristics
| Patient characteristics (n=56) | Mean±SD or No (%) |
| Age at cancer diagnosis (years) | 53.74±16.18 |
| Age at endocarditis diagnosis (years) | 59.54±15.32 |
| Sex | |
| Male | 31 (55.4%) |
| Female | 25 (44.6%) |
| Race/ethnicity | |
| Non-black (white/other) | 36 (64.3%) |
| Black | 20 (35.7%) |
| Diabetes mellitus | 43 (76.8%) |
| Congestive heart failure | 7 (12.5%) |
| Chronic kidney disease | 10 (17.9%) |
| Type of cancer | |
| Haematologic cancer | 18 (32.1%) |
| Solid cancer | 38 (67.9%) |
| Cancer status | |
| Cancer in remission | 20 (35.7%) |
| Active cancer | 36 (64.3%) |
| Chemotherapy treatment | |
| Not active | 22 (39.3%) |
| Active | 34 (60.7%) |
| Pacemaker | 4 (7.1%) |
| Catheter/line presence | 20 (35.7%) |
| Endocarditis location | |
| Mitral valve | 23 (41.1%) |
| Aortic valve | 20 (35.7%) |
| Tricuspid valve | 9 (16.1%) |
| Pacemaker lead | 2 (3.6%) |
| Superior Vena Cava | 2 (3.6%) |
| Vegetation >10 mm | 5 (8.9%) |
| Systemic emboli | 11 (19.6%) |
| Blood microorganism | |
| Streptococcus viridans | 7 (12.5%) |
| Streptococcus gallolyticus | 1 (1.8%) |
| Klebsiella | 1 (1.8%) |
| Staphylococcus aureus | 20 (35.7%) |
| Enterococcus | 10 (17.9%) |
| Negative culture | 17 (30.4%) |